Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €22.68 EUR
Change Today +0.076 / 0.34%
Volume 25.2K
As of 4:47 AM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for qiagen n.v. (QIA)

Year over year, Qiagen NV has been able to grow revenues from $1.3B USD to $1.3B USD. Most impressively, the company has been able to reduce the percentage of sales devoted to cost of goods sold from 35.06% to 33.81%. This was a driver that led to a bottom line growth from $69.1M USD to $116.6M USD.
Currency in
Millions of US Dollars
As of:Dec 31
2011
Restated
Dec 31
2012
Restated
Dec 31
2013
Reclassified
Dec 31
2014
4 Year
Trend
Revenues1,169.71,254.51,302.01,344.8
TOTAL REVENUES1,169.71,254.51,302.01,344.8
Cost of Goods Sold404.8438.6456.5454.6
GROSS PROFIT764.9815.8845.5890.1
Selling General & Admin Expenses, Total412.0450.1486.6492.7
R&D Expenses130.6122.5146.1163.6
Depreciation & Amortization, Total26.736.135.537.1
OTHER OPERATING EXPENSES, TOTAL569.4608.7668.2693.4
OPERATING INCOME195.5207.1177.3196.7
Interest Expense-25.4-23.5-30.9-39.3
Interest and Investment Income6.12.42.34.0
NET INTEREST EXPENSE-19.2-21.1-28.6-35.4
Currency Exchange Gains (Loss)12.4-7.25.61.9
Other Non-Operating Income (Expenses)3.57.00.40.5
EBT, EXCLUDING UNUSUAL ITEMS192.1185.9154.7163.8
Merger & Restructuring Charges-95.9-48.6-120.7-37.1
Gain (Loss) on Sale of Investments---3.4-3.4-4.8
Other Unusual Items, Total--11.36.7-3.4
Other Unusual Items--11.311.1-3.4
EBT, INCLUDING UNUSUAL ITEMS96.2145.237.3118.5
Income Tax Expense1.315.6-31.81.3
Minority Interest in Earnings1.10.00.0-0.6
Earnings from Continuing Operations94.9129.569.1117.2
NET INCOME96.0129.569.1116.6
NET INCOME TO COMMON INCLUDING EXTRA ITEMS96.0129.569.1116.6
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS96.0129.569.1116.6
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
QIA:GR €22.68 EUR +0.076

QIA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bio-Rad Laboratories Inc $149.95 USD -0.66
BioMerieux €96.46 EUR -0.02
Cepheid $61.13 USD -0.02
Myriad Genetics Inc $34.34 USD +0.35
PerkinElmer Inc $52.49 USD -0.15
View Industry Companies
 

Industry Analysis

QIA

Industry Average

Valuation QIA Industry Range
Price/Earnings 52.2x
Price/Sales 4.3x
Price/Book 2.3x
Price/Cash Flow 39.2x
TEV/Sales 3.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact QIAGEN N.V., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.